Literature DB >> 6096626

Adrenocortical suppression by a single induction dose of etomidate.

B Allolio, R Stuttmann, U Leonhard, H Fischer, W Winkelmann.   

Abstract

In a prospective controlled trial we studied the effect of a single induction dose of etomidate or thiopentone on the adrenocortical function in 29 patients undergoing elective surgery. During anesthesia and in the recovery period serum cortisol rose significantly in the thiopentone group only. In contrast, after induction with etomidate serum cortisol decreased and remained below the starting values throughout the study period (5 h). The differences between the two groups were significant at 120, 150, 180, 210, and 240 min after induction (p less than 0.05). Moreover, plasma ACTH increased significantly more after etomidate than after thiopentone (p less than 0.02) indicating relative unresponsiveness of the adrenal cortex to stimulation by endogenous ACTH. We conclude that a single i.v. bolus of etomidate (0.26 mg/kg) leads to significant adrenal insufficiency in patients without preexisting endocrine abnormalities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096626     DOI: 10.1007/bf01711723

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  [The influence of etomidate on blood gases and haemodynamics in patients with myocardial disease (author's transl)].

Authors:  G Hempelmann; W Hempelmann; S Piepenbrock; W Oster; G Karliczek
Journal:  Anaesthesist       Date:  1974-10       Impact factor: 1.041

2.  Effect on plasma cortisol concentrations of a single induction dose of etomidate or thiopentone.

Authors: 
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

3.  Suppression by etomidate of normal cortisone response to anaesthesia and surgery.

Authors:  J W Sear; M C Allen; M Gales; H J McQuay; N H Kay; P J McKenzie; R A Moore
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

4.  Influence of sedation on mortality in critically ill multiple trauma patients.

Authors:  I M Ledingham; I Watt
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

5.  Inhibition by etomidate of steroidogenesis in isolated bovine adrenal cells.

Authors:  C J Kenyon; J Young; C E Gray; R Fraser
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

6.  Etomidate and corticotrophic axis.

Authors:  P Preziosi; M Vacca
Journal:  Arch Int Pharmacodyn Ther       Date:  1982-04

7.  Effect of epidural analgesia on glucose tolerance during surgery.

Authors:  C H Jensen; P Berthelsen; C Kühl; H Kehlet
Journal:  Acta Anaesthesiol Scand       Date:  1980-12       Impact factor: 2.105

8.  Adrenocortical suppression in multiply injured patients: a complication of etomidate treatment.

Authors:  I W Fellows; M D Bastow; A J Byrne; S P Allison
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

9.  Inhibition of adrenal steroidogenesis by the anesthetic etomidate.

Authors:  R L Wagner; P F White; P B Kan; M H Rosenthal; D Feldman
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

10.  Effect of meclastine, an H1-antihistamine, on plasma ACTH in adrenal insufficiency.

Authors:  B Allolio; W Winkelmann; F X Hipp
Journal:  Acta Endocrinol (Copenh)       Date:  1981-05
View more
  18 in total

1.  ICU physicians should abandon the use of etomidate!

Authors:  Djillali Annane
Journal:  Intensive Care Med       Date:  2005-01-27       Impact factor: 17.440

Review 2.  Clinical and molecular pharmacology of etomidate.

Authors:  Stuart A Forman
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

3.  Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.

Authors:  Ervin Pejo; Yan Feng; Wei Chao; Joseph F Cotten; Ri Le Ge; Douglas E Raines
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

4.  Missing effect of etomidate on testosterone secretion in man.

Authors:  B Allolio; R Stuttmann; W Winkelmann
Journal:  Klin Wochenschr       Date:  1986-01-15

Review 5.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 6.  Acute lung failure.

Authors:  Rob Mac Sweeney; Daniel F McAuley; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2011-10-11       Impact factor: 3.119

Review 7.  [Etomidate for intravenous induction of anaesthesia].

Authors:  C Dumps; D Bolkenius; E Halbeck
Journal:  Anaesthesist       Date:  2017-12       Impact factor: 1.041

8.  The use of etomidate for rapid sequence induction in septic patients.

Authors:  Matthew R Dettmer; R Phillip Dellinger
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

9.  Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.

Authors:  Jason A Campagna; Kevin Pojasek; David Grayzel; John Randle; Douglas E Raines
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892

10.  Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis.

Authors:  M M Weber; J Lang; F Abedinpour; K Zeilberger; B Adelmann; D Engelhardt
Journal:  Clin Investig       Date:  1993-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.